Multiple-ascending dose study to assess the safety, tolerability and pharmacokinetics of AZD9977 in healthy male subjects

Trial Identifier: D6401C00001
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT03435276
Start Date: February 2018
Primary Completion Date: June 2018
Study Completion Date: June 2018
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
English Translation

Trial Locations

Country Location
United Kingdom Harrow, United Kingdom, HA1 3UJ